key: cord-0924556-ydidbggo
authors: Birol Ilter, P.; Prasad, S.; Mutlu, M. A.; Tekin, A. B.; O'Brien, P.; von Dadelszen, P.; Magee, L. A.; Tekin, S.; Tug, N.; Kalafat, E.; Khalil, A.
title: Maternal and perinatal outcomes of SARS‐CoV‐2 infection in unvaccinated pregnancies during Delta and Omicron waves
date: 2022-04-20
journal: Ultrasound Obstet Gynecol
DOI: 10.1002/uog.24916
sha: 35d8d8d0d79cd0abb3ca76662b32499e8dc422ad
doc_id: 924556
cord_uid: ydidbggo

OBJECTIVES: Currently, there is little evidence related to the effects of the Omicron variant on pregnancy outcomes, particularly in unvaccinated women. This study aims to compare pregnancy outcomes of SARS‐CoV‐2 infected, unvaccinated women during the pre‐Delta, Delta, and Omicron waves. METHODS: This was a retrospective cohort study at two tertiary care facilities: Sancaktepe Training and Research Hospital, Istanbul, Turkey, and St. George's University Hospitals NHS Foundation Trust, London, UK. Included were people testing RT‐PCR positive for SARS‐CoV‐2 during pregnancy, between April 01, 2020 and February 14, 2022, and divided into three epochs: (i) pre‐Delta, 1 Apr 2020 to 8 Jun 2021 in Turkey, and 1 Apr 2020 to 31 Jul 2021 in the UK; (ii) Delta, 9 Jun 2021 to 27 Dec 2021 in Turkey, and 1 Aug 2021 to 27 Dec 2021 in the UK; and (iii) Omicron, after 27 Dec 2021 in each of Turkey and the UK, according to the date of their positive RT‐PCR test. Baseline data collected included maternal age, parity, body mass index (BMI), smoking status, gestational age at diagnosis, and comorbidities. The primary outcome was the need for oxygen supplementation, classified as oxygen support via nasal cannula or breather mask, non‐invasive mechanical ventilation with continuous positive airway pressure (CPAP) or high‐flow oxygen, mechanical ventilation with intubation, or extracorporeal membrane oxygenation (ECMO). Inferences were made after balancing of confounders, using an evolutionary search algorithm. RESULTS: 1285 RT‐PCR‐proven SARS‐CoV‐2 infections of unvaccinated pregnant women were identified during the pre‐Delta (N=870), Delta (N=339), and Omicron (N=77) epochs. In the confounder‐balanced cohort, infection during the Delta wave was associated with increased need for nasal oxygen support (RR 2.53, 95% confidence interval [CI] 1.75‐3.65, P<.001), CPAP or high‐flow oxygen (RR 2.50, 95% CI 1.37‐4.56, P=.002), mechanical ventilation (RR 4.20, 95% CI 1.60‐11.0, P=.003), and ECMO (RR 11.0, 95% CI 1.43‐84.7, P=.021). The maternal mortality rate was also 3‐4 fold higher during the Delta wave compared to pre‐Delta (5.3% vs 1.5%, P=0.010). An infection during the Omicron wave was not associated with an increased need for nasal oxygen support (RR 0.62, 95% CI 0.25‐1.55, P=0.251), CPAP or high‐flow oxygen (RR 1.07, 95% CI 0.36‐3.12, P=0.906), or mechanical ventilation (RR 0.44, 95% CI 0.06‐3.45, P=0.438). The maternal mortality rate was similar during the Omicron wave and the pre‐Delta period (1.3% vs 1.3%, P=0.999). Nasal oxygen support during the Omicron wave was significantly lower compared to Delta‐wave infection (RR 0.26, 95% CI 0.11‐0.64, P=0.003). Perinatal outcomes were available for a subset of the confounder‐balanced cohort. Preterm birth below 34 weeks’ gestation was significantly increased (P<0.001) during the Delta wave compared with pre‐Delta. CONCLUSIONS: Among unvaccinated pregnant women, SARS‐CoV‐2 infection during (vs. before) the Delta wave was associated with increased requirement for oxygen support (including ECMO) and higher maternal mortality. Disease severity and pregnancy complications were similar during the Omicron wave (vs. pre‐Delta). SARS‐CoV‐2 infection in unvaccinated pregnant women carries considerable risks of morbidity and mortality, and COVID‐19 vaccination remains key. Miscommunication of risks of Omicron infection may adversely impact the vaccination rate among pregnant women, who are already at increased risk of complications related to COVID‐19. This article is protected by copyright. All rights reserved.

During the COVID-19 pandemic, there have been several peaks of infection, caused primarily by SARS-CoV-2 variants of concern (VOC), labelled alphabetically in chronological order. The first few pandemic peaks were caused by the wild-type and Alpha variant (B.1.1.7), against which available vaccines render strong immunity. The Delta variant (B.1.617) was more virulent than Alpha, and demonstrated some immune escape from vaccines, making them somewhat less effective 1 . The more recent Omicron variant (B.1.1.529) has shown even greater immune escape, leading to record case numbers (but not increased mortality) in every country where it was detected 2 3 . This has been widely interpreted to mean that the Omicron variant is less virulent; however, health authorities have advised caution, as data on Omicron infection have been derived largely from countries with high vaccination rates 4 .

COVID-19 disease is associated with excess maternal and perinatal mortality and morbidity 5 .

Some evidence suggests that the Delta variant (compared with the wild-type strain and Alpha variant) causes more severe disease in pregnancy and a heightened risk of stillbirth 6 .

However, there is little evidence related to the effect of the Omicron variant on pregnancy outcomes, particularly in unvaccinated women. This study aims to compare pregnancy outcomes of SARS-CoV-2 infected, unvaccinated women during the pre-Delta, Delta, and Omicron epochs.

This was a retrospective cohort study at two tertiary care facilities: Sancaktepe Training and Testing indications for SARS-CoV-2 included admission for obstetric indication (e.g., birth episode), COVID-19 symptomatology, and exposure to someone with confirmed SARS-CoV-2 infection. The management of infected women was similar in both centers. Oxygen supplementation with nasal cannula was started for women with oxygen saturation below 95%, severe shortness of breath, or tachypnea. When target oxygen saturation was not maintained on standard flow, the level of oxygen support was escalated to breather mask with reservoir and high-flow oxygen. Women who required high-flow oxygen support to maintain a target oxygen saturation were started on steroid treatment. Non-invasive mechanical ventilation with continuous positive airway pressure (CPAP), mechanical ventilation with intubation, and extracorporeal membrane oxygenation (ECMO) were utilized in sequential manner in women failing to maintain target oxygen saturation levels. Processes of care that were not included as outcomes were maternal intensive care unit (ICU) admission, and therapies such as convalescent plasma, remdesivir, and interleukin inhibitors; indications for their use varied between the study centers and during different stages of the pandemic.

Study data were collected from electronic records, and included baseline characteristics (such as maternal age, parity, body mass index [BMI], smoking status, gestational age at diagnosis and comorbidities), maternal complications, and perinatal outcomes. The main outcome measure was the need for respiratory support, with levels classified as oxygen support via nasal cannula or breather mask, CPAP or high-flow oxygen, or mechanical ventilation with intubation or ECMO.

Baseline characteristics and outcomes were compared using Chi-squared, Fisher's exact test, t-test, or Mann-Whitney-U test, as appropriate. Confounders were selected from the published literature. Exposure groups (pre-Delta vs. Delta and pre-Delta vs. Omicron) were matched for confounders using propensity score matching with an evolutionary search algorithm. Selected confounders were maternal age, body-mass index and gestational age at diagnosis 8 . The confounders were investigated and chosen among a set of candidate variables (maternal age, body-mass index, parity, gestational age at diagnosis, comorbidities) in a previous study based on a similar cohort 8 . Balance was optimized for the confounders and the balance checks were performed using propensity score histograms and randomization checks for Mahalanobis distance. Standardized mean differences in baseline characteristics between the groups were calculated with the aim of reducing differences below 10%. Matching ratio was selected with the aim of minimizing discarded subjects (i.e., unmatched individuals) and reaching optimal confounder balance.

Sensitivity analyses were performed with smaller and larger matching ratios, to check the robustness of estimates. Also, after matching, the effects were estimated using generalized estimating equations, thereby avoiding potential bias from exclusion of cases for which confounder-matching could not be achieved; match identifiers were treated as random-effects, while variant wave and other predictor variables were treated as fixed-effects. Stability of estimates were tested with generalized linear-mixed effects models using both match identifiers and treatment centers as random-effects but these set of results were not reported if both analyses had similar results.

Effect estimates were reported as risk ratios and 95% confidence intervals (CI). All analyses were performed using R for Statistical Computing Software (Vienna, Austria) and P values less than 0.05 were considered statistically significant.

CoV-2 infection were identified, during the pre-Delta (N=870), Delta (N=339), and Omicron (N=77) epochs. Majority of the cases were from Turkey (n=1159) and the remainder from UK (n=126).

Among our study population, the rates of mechanical ventilation (invasive or non-invasive) were 6.2% pre-Delta, 14.7% during the Delta wave, and 4.7% during the Omicron wave. The bimonthly average proportion of positive cases requiring mechanical ventilation reached a peak towards the second half of the Delta wave (22.1%), followed by a precipitous drop during the Omicron wave (to 4.7%) ( Figure 1 ). Table 1 shows that pregnant women infected with SARS-CoV-2 during (vs. before) the Delta wave were slightly older, with higher BMI, and later gestational age at diagnosis (including diagnosis in the third trimester), all factors known to increase the risk of severe COVID-19.

After 1:1 matching for baseline characteristics, the confounder-balanced cohort showed standardized mean differences in baseline factors that were small and within 10% (Table 1, Figure S1a ). Table 2 shows that in the confounder-balanced cohort, SARS-CoV-2 infection during the Delta (vs. pre-Delta) wave was associated with an increased need for oxygen supplementation, defined by heightened need for nasal oxygen support, CPAP or high-flow oxygen, mechanical ventilation, and ECMO. In addition, in the Delta (vs. pre-Delta) epoch, maternal death was 3-4 fold higher (5.3% vs. 1.5%, P=0.010) and very preterm birth (prior to 34+0 weeks' gestation) significantly increased (15.4% vs. 4.9%, P<0.001). The rates of preeclampsia, preterm birth before 37+0 weeks' gestation, and stillbirth did not differ between Delta and pre-Delta epochs, although absolute rates were higher in the Delta-dominant period.

Pre-Delta period vs Omicron wave infections Table 3 shows that pregnant women infected during the Omicron wave (vs. pre-Delta period) were heavier, and acquired their infection at a much later gestational age. As such, women infected during the Delta wave (vs. pre-Delta) had a much higher baseline risk of severe COVID-19. A 4:1 match of pre-Delta and Omicron wave infection cases was needed for adequate balancing in the confounder-balanced cohort, achieving standardized mean differences in baseline characteristics between the groups within 10% (Table 3, Figure S1b ). Table 4 shows that in the confounder-balanced cohort, infection during the Omicron wave (vs.

pre-Delta epoch) was associated with a similar need for oxygen supplementation, however defined, and there were no differences in maternal death or preeclampsia. Also, for the subset of the cohort for which delivery outcomes were available, there were no differences in preterm birth or stillbirth during the Omicron wave (vs. the pre-Delta epoch). The 95% CI are wide, and include important potential harms and benefits associated with Omicron (vs. pre-Delta) epochs.

Omicron period vs Delta wave infections Table S1 shows that in the confounder-balanced cohort, infection during the Omicron wave (vs. Delta epoch) was associated with a 74% reduced risk of nasal oxygen support (24.7% vs.

6.5%). While, invasive respiratory support (4.5 vs 1.3%, Delta vs. Omicron, respectively) and maternal death (3.2 vs. 1.3%) was lower in the Omicron (vs. Delta) epoch, differences did not reach statistical significance.

Without excluding any data, and adjusting for any effects of confounders via multiple logbinomial regression, our results agreed with the previous analysis that infection during the Delta wave was associated with a significantly greater need for advanced respiratory support (invasive or non-invasive mechanical ventilation; adjusted RR 2.19, 95% CI 1.44-3.35, P<0.001), while no significant difference was observed during the Omicron (vs. pre-Delta) epoch (adjusted RR 0.78, 95% CI 0.23-1.95, P=0.644) ( Table 5 ). The factors associated with requirement for advanced respiratory support (non-invasive or invasive mechanical ventilation) using generalized estimating equations with log-binomial link function using treatment centers as clusters are shown in Table 5 .

Among unvaccinated pregnant women, SARS-CoV-2 infection during the Delta wave (vs. pre-Delta) was associated with increased requirement for oxygen support (including ECMO) and higher maternal mortality. Conversely, infection severity and complications during the Omicron wave were similar, and not significantly milder, compared with the pre-Delta period. Our findings were consistent among confounder-matched cohort estimates and multiple regression-adjusted estimates. While we cannot rule out smaller effects for a milder disease course during the Omicron wave, SARS-CoV-2 infection in unvaccinated pregnant women still carried considerable risks for both morbidity and mortality.

The main strengths of this study are, first, that it provides data related to maternal and perinatal 

In our study, we observed a more severe clinical course in infected pregnant women during the Delta wave, and maternal mortality was increased. These findings are consistent with the limited literature on SARS-CoV-2 VOCs and greater severity of maternal disease during the Delta wave 6, 9 . All related studies have taken our approach of using the date of SARS-CoV-2 infection as a surrogate for viral variant, as genotyping each infection is not commonly available. While the absolute rate of stillbirth in our study did not reach statistical significance, the report from the Centers for Disease Control (CDC) and Prevention, United States, found that infections during the Delta wave were associated with an increased incidence of stillbirth, compared with previous waves (i.e., wild type and Alpha variant) 6 ; the more severe infections during the Delta wave raises the possibility that disease severity is a mediator of stillbirth. Our findings are not consistent with widely-reported observations that the Omicron variant is associated with less severe clinical infection outside pregnancy.

As yet, there are no data on the severity of Omicron infection in unvaccinated pregnant women compared with previous variants. A recent report from our group showed that vaccinated women infected during the Omicron wave had neither moderate nor severe disease, while unvaccinated pregnant women were more likely to need oxygen support 10 . This emphasizes the importance of vaccination to pregnant women, even during the Omicron wave, during which the efficacy of vaccination against SARS-CoV-2 infection is diminished. Vaccination with an mRNA vaccine is safe and effective, but is still underutilized in pregnant women 11, 12 .

Pregnant women already have high levels of vaccine hesitancy, and miscommunication of protective effects of the vaccine or risk associated with COVID-19 could have dire consequences 11 . While there is widespread media coverage of reduced virulence of SARS-CoV-2 during the Omicron wave, our data suggest that this is not the case for unvaccinated pregnant women. This must be emphasized in public messaging. Moreover, further research is required for assessing the effectiveness of available vaccines (e.g. mRNA, viral vector) for preventing SARS-CoV-2 infection and related morbidities in pregnant women.

In unvaccinated pregnant women, infections during the Delta wave were more severe compared with previous waves; however, there was no clear evidence of reduced severity during the Omicron (vs. pre-Delta) wave. Miscommunication of risks may adversely influence the vaccination rate among pregnant women, who are already at increased risk of adverse maternal and perinatal events related to COVID-19. 

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion

Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron

Severity with Omicron Variant in South Africa

Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis

Erratum in: Lancet Glob Health

Risk for Stillbirth Among Women With and Without COVID-19 at Delivery Hospitalization -United States

An internally validated prediction model for critical COVID-19 infection and intensive care unit admission in symptomatic pregnant women

Impact of SARS-CoV-2 variant on the severity of maternal infection and perinatal outcomes: Data from the UK Obstetric Surveillance System national cohort

Clinical severity of SARS-CoV-2 infection among vaccinated and unvaccinated pregnancies during the Omicron wave

COVID-19 vaccination during pregnancy: coverage and safety

SARS-CoV-2 vaccination in pregnancy: a unique opportunity for equity